Financial News Feed

Stronger Sell Today ABEO ranks #4236 as SELL CANDIDATE. Weaker Sell
Today ABEO ranks #4236 as SELL CANDIDATE.

ABEO stock Abeona Therapeutics Inc.

ABEO stock
Abeona Therapeutics Inc.

Ichimoku traders are closely watching shares of Abeona Therapeutics (ABEO) as the equity’s price has tipped below the Tenkan moving average line, creating an environment ripe for a potential near-te...

Read more

Following recent price action, Abeona Therapeutics (ABEO) shares have been identified trading above the Chikou. When the stock is above this signal, traders will be looking out for possible upward mom...

Read more

Studying the short-term chart on shares of Abeona Therapeutics (ABEO), we have noted that the current 20-Day Bollinger Bands signal is presently reading Hold. This indicator may be used to assist with...

Read more

Investors may be looking into the crystal ball trying to calculate where the equity market will be shifting as we move into the second half of the year. Investors may be hard pressed to find bargains ...

Read more

Abeona Therapeutics (NASDAQ:ABEO) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report released on Saturday. A number of other brokera...

Read more

Abeona Therapeutics Inc. (NASDAQ:ABEO) Ratings Coverage Among 2 analysts covering Abeona Therapeutics (NASDAQ:ABEO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Abeona Therapeut...

Read more

Examining shares of Abeona Therapeutics Inc. (NASDAQ:ABEO), we can see that the stock has a current beta of 2.20. Checking in on current price action, company shares had recently touched 7.14. From th...

Read more

Wall Street brokerage firm analysts have placed a “Buy” rating on shares of Abeona Therapeutics Inc. (NASDAQ:ABEO). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell a...

Read more

Abeona Therapeutics Inc. (NASDAQ:ABEO) Ratings Coverage Among 2 analysts covering Abeona Therapeutics (NASDAQ:ABEO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Abeona Therapeut...

Read more

(RTTNews) - Today's Daily Dose brings you news about preliminary financial results of Globus Medical, Conformis, and GenMark Diagnostics; approval of Amgen/UCB's osteoporosis drug Evenity in Japan; Ge...

Read more

(MENAFN - GlobeNewsWire - Nasdaq) itemprop="articleBody">NEW YORK and CLEVELAND, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage......

Read more

Checking the numbers for Abeona Therapeutics (ABEO), we have seen that the Kaufman Adaptive Moving Average is trending lower over the past five sessions. Traders watching this indicator may be looking...

Read more

The stock of Abeona Therapeutics Inc (NASDAQ:ABEO) registered a decrease of 1.94% in short interest. ABEO’s total short interest was 10.07M shares in January as published by FINRA. Its down 1.94% fr...

Read more

Abeona Therapeutics Inc (NASDAQ:ABEO) dropped 5.8% on Thursday . The stock traded as low as $6.51 and last traded at $6.62. Approximately 538,470 shares changed hands during mid-day trading, an increa...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank